Ethanol → (3aR,5R,6S,7R,7aR)-2-(ethylamino)-5-[(4-pyridin-2-yltriazol-1-yl)methyl]-5,6,7,7a-tetrahydro-3aH-pyrano[3,2-d][1,3]thiazole-6,7-diol
Reaction equation
[N:1]([CH2:4][C@H:5]1[O:13][C@H:12]2[C@H:8]([N:9]=[C:10]([NH:14][CH2:15][CH3:16])[S:11]2)[C@@H:7]([OH:17])[C@@H:6]1[OH:18])=[N+:2]=[N-:3].C(O)C.[C:22]([C:24]1[CH:29]=[CH:28][CH:27]=[CH:26][N:25]=1)#[CH:23]>[Cu].O.O.O.O.O.S([O-])([O-])(=O)=O.[Cu+2].O.CC(O)(C)C>[CH2:15]([NH:14][C:10]1[S:11][C@H:12]2[O:13][C@H:5]([CH2:4][N:1]3[CH:23]=[C:22]([C:24]4[CH:29]=[CH:28][CH:27]=[CH:26][N:25]=4)[N:3]=[N:2]3)[C@@H:6]([OH:18])[C@H:7]([OH:17])[C@H:8]2[N:9]=1)[CH3:16]Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 4
Procedure
In a 5 mL seal vial equipped with a stir bar, a septum was added (3aR,5R,6S,7R,7aR)-5-(azidomethyl)-2-(ethylamino)-5,6,7,7a-tetrahydro-3aH-pyrano[3,2-d][1,3]thiazole-6,7-diol (40.00 mg; 0.15 mmol; 1.00 eq.), copper Not supported by ACD (65.10 mg; 1.02 mmol; 7.00 eq.) and copper (2+) sulfate pentahydrate (7.31 mg; 0.03 mmol; 0.20 eq.). The vial was evacuated and filled with N2. This procedure was repeated for twice before ethanol (0.40 ml)/water (0.60 ml)/2-methylpropan-2-ol (1.00 ml) and 2-ethynylpyridine (0.03 ml; 0.29 mmol; 2.00 eq.) was added into the mixture. The mixture was stirred at room temperature for overnight before 3 mL H2O was added into the mixture and dried via lyophilization. The mixture was purified with Yamazen C1 acidic condition affording 14.4 mg (20.1%) of the title compound as a white solid (HPLC 99%, retention time=1.73 min) once lyophilized.
Workup
- customIn a 5 mL seal vial
- customequipped with a stir bar
- customThe vial was evacuated
- additionfilled with N2
- additionwas added into the mixture
- additionwas added into the mixture
- customdried via lyophilization
- customThe mixture was purified with Yamazen C1 acidic condition
Sources & evidence
- ORD record
- ord-74622ff6de5c450cb416fb212d82cd9b
- Source dataset
- uspto-grants-2014_11
- Patent number
- US08884023B2
Reaction notes
Loading…